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Abstracts / Osteoarthritis and Cartilage 22 (2014) S7–S56S10the secondary outcomes ICOAP intermittent and constant pain (stat-
istically signiﬁcant and clinically relevant differences between the
groups at 3 months but not at 12 months follow-up), but not for the
other outcomes (no differences between the groups at 3 months and at
12 months follow-up). No adverse events were reported during the
study.
Conclusions: At 3 months follow-up there was a statistical signiﬁcant
difference between the treatment groups in favor of the group allocated
to exercise therapy on the primary outcomes HOOS pain and HOOS
function and also in the secondary outcome ICOAP. At 12 months fol-
low-up there were no statistical differences between the treatment
groups.
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Purpose: Throughout our lifespan, maintenance of synovial joint
integrity is essential for quality of life. While much is known about the
susceptibility of synovial joints to common pathologies such as age-
dependent and post-traumatic osteoarthritis, basic information about
their developmental biology is surprisingly limited. Previously, research
from our group demonstrated that Gdf5-expressing mesenchymal
interzone cells forming at presumptive limb joint sites give rise to
multiple joint tissues during embryonic development including artic-
ular cartilage, ligaments and synovial lining. What had remained
unknown, however, is whether spatiotemporal differences in genesis of
Gdf-5 expressing cells results in selective participation in development
of speciﬁc joint tissues, and what roles Gdf-5 expressing cells may have
in postnatal joint phenotype and function. To address these and related
questions, we carried out detailed Gdf-5 cell lineage tracing during late
embryonic and postnatal joint development using our existing Gdf5-
Cre mouse line as well as a novel Gdf5-CreERT2 line.
Methods: Female Gdf5-Cre transgenic mice were mated with male
ROSA-mTomato/mGFP (mTmG) reporter mice which express con-
stitutive red ﬂuorescence prior to, and conditional green ﬂuorescence
following, Cre-mediated recombination. Offspring were harvested at
embryonic day 18.5 (E18.5) and postnatal day 0, 14 or 28 (P0, P14 or
P28). Female mice from our new Gdf5-CreERT2 transgenic strain were
mated with male ROSA-tdTomato reporter mice which express red
ﬂuorescent protein in cells following Cre-mediated recombination.
Gdf5-CreERT2 females were injected with tamoxifen at E14.5 and E15.5,
and resulting embryos were harvested at E18.5.
Results: Cre-dependent lacZ reporter strains (ROSAR26R) are widely
used for cell lineage and fate map tracing. However, endogenous b-
galactosidase expression in postnatal skeletal tissues leads to back-
ground staining and difﬁculties in interpreting Cre expression patterns.
Indeed, b-galactosidase staining of sections from P14 Gdf-5Cre;R26R
mouse knees was present in bone areas (Figure 1A, arrows) in addition
to predicted expression patterns in articular cartilage (AC, arrowhead),
synovial lining (SL, arrowhead) and capsule tissue (CT, arrowhead). In
contrast, expression of mGFP in complementary Gdf-5Cre;ROSA-mTmG
mice was limited to articular cartilage, synovial lining and capsule tis-
sue (Figure 1B, arrowheads). When tamoxifenwas injected at E14.5 and
E15.5 in our novel Gdf5-CreERT2;ROSAtdTomato mice, we found that
selective labeling was present in superﬁcial articular cells and synovial
lining by E18.5 (Figure 2,A). In comparison, continuous joint progenitor
labeling in standard Gdf-5Cre;ROSA-mTmG mice generated broader
labeling of articular cell layers and synovial cells (Figure 2, B). To
monitor fate and function of labeled cells, Gdf-5Cre;ROSA-mTmG mice
were sacriﬁced at successive postnatal ages. In neonatal mice, mGFP-
expressing cells were present throughout the epiphyseal articular car-
tilage of femur, extending several cell layers below the articular surface
(Figure 2, C). Interestingly, the mGFP expression patterns became more
restricted by P14, with several mGFP-negative cells present in the two
most superﬁcial cell layers (Figure 2D). Patterns of decreasing expres-
sion at the articular surface continued through P28 (Figure 2E).
Conclusions: Our data demonstrate the exciting potentials of the new
novel Gdf5-CreERT2 mouse line for studying spatiotemporal Gdf-5
activation in developing joints and indicate that CreER activation atE14.5 and E15.5 elicits reporter expression conﬁned to the most
superﬁcial layer of developing E18.5 articular cartilage. The constitutive
Gdf5-Cre line instead elicits reporter expression in several articular
layers by the same age. Though preliminary, the data from the novel
Gdf5CreER line suggests that sub-populations of progenitor cells exist
within a broader region of cells labeled by Gdf5Cre, hinting at their
diverse joint formation capacity. Our data from postnatal Gdf-5Crex-
ROSAmTmG mice indicate that not all articular chondrocytes are
reporter positive by P14 and P28. One possibility is that reporter
expression was partially lost over time. A far more interesting possi-
bility is that there may be an additional source of postnatal articular
progenitors, such as the groove of Ranvier.8
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